--- title: Buy Tenofovir Emtricitabine 300/200mg Tabs Online description: Tenofovir Emtricitabine 300/200mg tabs aid in HIV treatment and prevention. Order from our secure pharmacy for quality products and dependable delivery. type: product language: en url: https://medsforsale.net/buy-tenofovir-emtricitabine-online-en availability: in_stock price_min: 83.99 price_max: 193.99 currency: USD offers: - name: 300/200mg x 30 tabs price: 83.99 - name: 300/200mg x 60 tabs price: 143.99 - name: 300/200mg x 90 tabs price: 193.99 --- # Buy Tenofovir Emtricitabine 300/200mg Tabs Online Tenofovir Emtricitabine combines Tenofovir and Emtricitabine in tablet form. This fixed-dose combination is used for HIV-1 treatment and as pre-exposure prophylaxis to reduce infection risk. It is for adults at risk or managing HIV as prescribed. Available in 300/200mg tabs from our reliable online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **300/200mg** | 30 tabs | **$83.99** | $2.80 | In Stock | | **300/200mg** | 60 tabs | **$143.99** | $2.40 | In Stock | | **300/200mg** | 90 tabs | **$193.99** | $2.16 | In Stock | [Buy Now](https://medsforsale.net/buy-tenofovir-emtricitabine-online-en) ## Introduction Tenofovir Emtricitabine is a fixed-dose, oral tablet that combines two nucleos(t)ide reverse-transcriptase inhibitors (NRTIs). The medication is supplied in a 300 mg Tenofovir disoproxil fumarate / 200 mg Emtricitabine tablet. It belongs to the class of antiretroviral agents used to suppress human immunodeficiency virus type 1 (HIV-1) replication. The product is approved for treatment-naïve and treatment-experienced adults living with HIV, and it is also indicated for pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV infection. Off-label investigations have explored its role in hepatitis B virus (HBV) management and as part of HIV cure research. ## What is Tenofovir Emtricitabine? Tenofovir Emtricitabine is the generic version of well-known medications, containing the active compound Tenofovir/Emtricitabine. It is marketed in the United States and many other jurisdictions under brand names such as **Truvada** and **Descovy**. [our online pharmacy](https://medsforsale.net/buy-tenofovir-emtricitabine-online-en) provides this generic alternative as a cost-effective treatment option. The product is manufactured by several licensed pharmaceutical firms that are authorized by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). It is supplied as a film-coated tablet, each tablet delivering 300 mg of Tenofovir disoproxil fumarate (TDF) and 200 mg of Emtricitabine. ## How Tenofovir Emtricitabine Works Both Tenofovir and Emtricitabine are analogues of natural nucleotides. After oral absorption, Tenofovir is converted intracellularly to Tenofovir diphosphate, and Emtricitabine is phosphorylated to Emtricitabine triphosphate. These active metabolites compete with the natural deoxy-adenosine-5′-triphosphate and deoxy-cytidine-5′-triphosphate, respectively, for incorporation into the viral DNA chain by HIV-1 reverse transcriptase. When incorporated, they lack a 3′-hydroxyl group, causing premature termination of DNA elongation. This blocks the synthesis of proviral DNA, preventing integration of the viral genome into host cells and thereby reducing plasma HIV RNA levels. The antiviral effect begins within days of the first dose, peaks after several weeks of consistent therapy, and is maintained as long as adequate intracellular drug concentrations are preserved. ## Conditions Treated with Tenofovir Emtricitabine - **HIV-1 infection (treatment-naïve or experienced adults):** Used in combination with other antiretrovirals such as integrase inhibitors, protease inhibitors, or non-nucleoside reverse-transcriptase inhibitors. The combination provides a high barrier to resistance and robust viral suppression. - **Pre-exposure prophylaxis (PrEP) for HIV-1:** Taken daily by HIV-negative individuals at substantial risk of acquisition (e.g., men who have sex with men, serodiscordant couples). Clinical trials (e.g., iPrEx, DISCOVER) demonstrated up to 99 % reduction in HIV incidence when adherence is high. Both indications are FDA- and EMA-approved, based on extensive Phase III trial data confirming efficacy, safety, and tolerability. ## Off-Label and Investigational Uses of Tenofovir Emtricitabine - **Chronic hepatitis B virus (HBV) infection:** Tenofovir (as TDF) has strong activity against HBV, but the fixed-dose combination with Emtricitabine is not formally approved for HBV monotherapy. Some clinicians prescribe it off-label for patients co-infected with HIV/HBV, leveraging the dual activity of Tenofovir against both viruses. Evidence from observational studies suggests comparable viral suppression to Tenofovir alone, but formal regulatory approval is lacking. - **Post-exposure prophylaxis (PEP) for HIV:** While Tenofovir/Emtricitabine is a component of many PEP regimens, its use as a standalone PEP option is off-label and should only be employed under specialist guidance. - **HIV cure and reservoir-reduction studies:** Early-phase trials have examined intensified regimens that include Tenofovir/Emtricitabine to assess impacts on latent HIV reservoirs. These investigations remain experimental, and patients should not pursue such protocols outside of a registered clinical trial. All off-label applications must be discussed with a qualified healthcare provider. The safety profile for approved uses generally extends to these contexts, but efficacy and optimal dosing may differ. ## Is Tenofovir Emtricitabine the Right Medication for You? Tenofovir Emtricitabine is appropriate for adult patients who: - Have confirmed HIV-1 infection and require a backbone NRTI regimen in combination with other antiretrovirals. - Are HIV-negative but meet CDC criteria for PrEP (e.g., ongoing high-risk sexual activity, injection drug use). The drug is especially recommended for individuals who desire a once-daily, fixed-dose regimen that simplifies pill burden and promotes adherence. **Contraindications and cautions:** - Known hypersensitivity to Tenofovir, Emtricitabine, or any excipients in the tablet. - Severe renal impairment (creatinine clearance < 30 mL/min) or dialysis dependence, as dosage adjustment may be required. - Pregnancy and breastfeeding: While data do not show teratogenicity, clinicians should evaluate risks versus benefits. - Patients with active hepatitis B monoinfection should consider Tenofovir monotherapy or other approved HBV regimens to avoid unnecessary exposure to Emtricitabine. ## Risks, Side Effects, and Interactions ### Common - Nausea, vomiting, or abdominal discomfort. - Headache or mild fatigue. - Mild elevations in serum creatinine or reductions in estimated glomerular filtration rate (eGFR). ### Rare - Lactic acidosis or severe hepatomegaly with steatosis (more common in patients with underlying liver disease). - Dermatologic reactions such as rash or urticaria. - Bone mineral density loss with long-term use, particularly in post-menopausal women. ### Serious - Renal toxicity, including Fanconi syndrome or acute renal failure, especially when combined with other nephrotoxic agents (e.g., non-steroidal anti-inflammatory drugs, certain antivirals). - Severe hypersensitivity reactions (e.g., Stevens-Johnson syndrome). - Immune reconstitution inflammatory syndrome (IRIS) in patients initiating therapy with advanced immunosuppression. **Drug-drug interactions** - **Nephrotoxic agents** (e.g., cyclosporine, tacrolimus, amphotericin B) may exacerbate Tenofovir-related renal effects. - **Adefovir, other Tenofovir formulations, or high-dose oral valacyclovir** increase cumulative Tenofovir exposure, requiring dose modification. - **Proton pump inhibitors** have minimal effect but may delay absorption; spacing doses by at least 2 hours is advisable. **Drug-food considerations** - Tenofovir Emtricitabine can be taken with or without food; however, a meal may reduce gastrointestinal upset. - Alcohol should be consumed in moderation, as excessive intake can worsen hepatic and renal adverse effects. ## Use: Dosing, Missed Dose, Overdose - **Standard adult dosing for HIV treatment or PrEP:** One tablet (300 mg Tenofovir / 200 mg Emtricitabine) taken orally once daily, with or without food. - **Renal adjustment:** If creatinine clearance is 30-49 mL/min, some guidelines recommend extending the dosing interval to every 48 hours; patients with clearance < 30 mL/min should avoid the combination and discuss alternatives with a clinician. **Missed dose:** - If a dose is missed by less than 12 hours, take it as soon as remembered and continue the regular schedule. - If more than 12 hours have passed, skip the missed tablet and resume the next dose at the usual time. Do not double-dose. **Overdose:** - Symptoms may include nausea, vomiting, dizziness, or renal dysfunction. - Seek emergency medical attention; supportive care and monitoring of renal function are the primary interventions. There is no specific antidote. **Practical precautions:** - Avoid crushing or breaking the tablet unless a liquid formulation is prescribed. - Do not operate heavy machinery or drive if you experience dizziness or visual disturbances. - Maintain adequate hydration to support renal clearance. ## FAQ - **Can I travel internationally with Tenofovir Emtricitabine?** • Yes. Keep the medication in its original labeled container, carry a copy of the prescription or a doctor’s note, and store tablets at room temperature away from direct sunlight. - **Do I need to take Tenofovir Emtricitabine with food?** • The drug may be taken with or without meals. Taking it with food can lessen stomach upset for some patients, but consistent timing is more important for adherence. - **What does the tablet look like?** • The generic tablet is typically round, film-coated, and marked with “300/200” on one side to indicate the Tenofovirus and Emtricitabine strengths. Inactive ingredients may include lactose, magnesium stearate, and microcrystalline cellulose. - **Is Tenofovir Emtricitabine safe for people with hepatitis B only?** • The combination is not approved for HBV monotherapy. Though Tenofovir has strong anti-HBV activity, prescribing the fixed-dose combo without HIV co-infection is considered off-label and should only occur under specialist supervision. - **Will a routine drug test detect Tenofovir Emtricitabine?** • Standard employment drug screens do not test for antiretrovirals. Specialty testing can detect Tenofovir or Emtricitabine metabolites, but such testing is uncommon outside clinical or forensic settings. - **How should I store the medication in hot climates?** • Store the tablets at temperatures between 15 °C and 30 °C (59 °F-86 °F). In exceptionally hot environments, keep them in a climate-controlled area or a cooler container to prevent degradation. - **Are there any known interactions with contraceptive hormones?** • No clinically significant pharmacokinetic interactions have been identified between Tenofovir Emtricitabine and combined oral contraceptives, implants, or intrauterine devices. Patients can continue their usual contraceptive method. - **What clinical trials led to its approval for PrEP?** • The iPrEx trial (2010) demonstrated an 44 % reduction in HIV acquisition among MSM, rising to > 90 % with high adherence. The DISCOVER trial (2021) compared Tenofovir Emtricitabine/Descovy to Truvada, confirming non-inferior efficacy for PrEP. - **Can I switch from brand-name Truvada to the generic version?** • Yes. The generic formulation is bioequivalent to the brand-name products, provided it is sourced from a reputable, regulatory-compliant manufacturer. Discuss the switch with your prescriber to ensure continuity of care. - **Is it safe to use alcohol while on Tenofovir Emtricitabine?** • Moderate alcohol consumption is generally acceptable, but excessive intake can worsen liver and kidney side effects. Patients with pre-existing hepatic or renal disease should limit alcohol and discuss consumption levels with a clinician. ## Glossary **Reverse-Transcriptase Inhibitor (RTI)** : A class of antiretroviral drugs that block the reverse-transcriptase enzyme, preventing the conversion of viral RNA into DNA, which is essential for HIV replication. **PrEP (Pre-Exposure Prophylaxis)** : A preventive strategy where HIV-negative individuals at high risk take a daily antiretroviral medication to significantly lower the chance of acquiring HIV infection. **eGFR (Estimated Glomerular Filtration Rate)** : A calculated measure of kidney function based on serum creatinine, age, sex, and body size; used to assess suitability and dosing of renally cleared drugs like Tenofovir. ## Buying Tenofovir Emtricitabine from [our online pharmacy](https://medsforsale.net/buy-tenofovir-emtricitabine-online-en) Tenofovir Emtricitabine is readily available through **[our online pharmacy](https://medsforsale.net/buy-tenofovir-emtricitabine-online-en)**. By sourcing the generic formulation, patients can reduce medication costs to near-manufacturer pricing while maintaining the same therapeutic efficacy as brand-name products. All tablets are obtained from licensed, vetted suppliers who adhere to international Good Manufacturing Practices, ensuring product integrity and safety. Delivery is discreet and reliable, with express options typically arriving within seven business days and standard airmail within three weeks. Because we operate as a pharmacy broker service, we partner with overseas licensed pharmacies to provide access to medications that may be unavailable or unaffordable through local channels. Each order is packaged confidentially, respecting patient privacy throughout the fulfillment process. Our service is designed for individuals who encounter barriers such as limited insurance coverage, geographic constraints, or high out-of-pocket expenses. By choosing **[our online pharmacy](https://medsforsale.net/buy-tenofovir-emtricitabine-online-en)**, you gain a secure, cost-effective pathway to obtain Tenofovir Emtricitabine without compromising on quality or confidentiality. ## Disclaimer The information presented here about **Tenofovir Emtricitabine** serves only as general educational material and does not substitute for professional medical advice. All therapeutic decisions, including those concerning off-label uses, should be undertaken under the direct supervision of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health choices. **[our online pharmacy](https://medsforsale.net/buy-tenofovir-emtricitabine-online-en)** offers access to Tenofovir Emtricitabine for individuals who may encounter limited availability through conventional pharmacies, insurance formularies, or who seek affordable generic alternatives. Always discuss any medication changes with your clinician before initiating, modifying, or discontinuing treatment.